UK Launches First COVID-19 Vaccine Trial Eight Weeks into Ebola Emergency

A new Ebola vaccine developed at the University of Oxford has received regulatory approval to begin human clinical trials in the UK. The vaccine, created in response to an ongoing outbreak of the Bundibugyo species of Ebola, was developed rapidly using existing technology similar to the Oxford/AstraZeneca COVID vaccine. Trials will involve 50 healthy adults, with monitoring for immune response and side effects, and are part of broader efforts to combat the disease, which has caused over 600 deaths in the Democratic Republic of the Congo.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article